Cytek Biosciences, Inc. - Common Stock — Cash Flow (NASDAQ:CTKB) | MetaTrader

Open full chart

Financials

Overview Statement Statistics Documents

Quarterly Annual

Cash from operating activities 4.63 M-12.23 M5.28 M25.38 M-4.69 M -6.04 M Cash from investing activities -20.99 M-55.91 M-93.89 M-82.97 M10.12 M -2.98 M Cash from financing activities 213.56 M5.51 M-41.81 M-15.82 M-13.43 M 3.88 M Free cash flow 4.63 M-12.23 M5.28 M25.38 M-8.88 M -12.17 M

News

Cytek Biosciences, Inc. (CTKB) Q2 2026 Earnings Call Transcript

Cytek Biosciences, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:CTKB) 2026-08-06

Cytek Biosciences, Inc. (CTKB) Reports Q2 Loss, Tops Revenue Estimates

Kyntra Bio (KYNB) Expected to Beat Earnings Estimates: Should You Buy?

Analysts Estimate Cytek Biosciences, Inc. (CTKB) to Report a Decline in Earnings: What to Look Out for

CSBR vs. CTKB: Which Life Sciences Stock Has Better Long-Term Upside?

Cytek Biosciences, Inc. (CTKB) Presents at Singular Research's Las Vegas Invitational Conference - Slideshow (NASDAQ:CTKB) 2026-06-15

Cytek Biosciences, Inc. (CTKB) Reports Q1 Loss, Beats Revenue Estimates

Cytek Biosciences at TD Cowen Health Care: Strategic Growth Insights

Cytek Biosciences, Inc. (CTKB) Q4 2025 Earnings Call Transcript

Cytek Biosciences, Inc. (CTKB) Reports Q4 Loss, Tops Revenue Estimates

Cytek Biosciences earnings missed by $0.32, revenue topped estimates